ad image

Recall

1 / 1
Teva Pharmaceutical Industries
Recall

Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride

Teva Pharmaceutical Industries

PR-M06-20-NI-025-1496Jun 18, 2020
Takeda
Recall

Takeda Issues US Recall of Two Lots of VONVENDI

Takeda

PR-M02-20-NI-038Feb 27, 2020
U.S. Food & Drug Administration
Recall

FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)

U.S. Food & Drug Administration

PR-M10-19-NI-047Oct 30, 2019
U.S. Food & Drug Administration
Recall

Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets

U.S. Food & Drug Administration

PR-M09-19-NI-055Sep 27, 2019
U.S. Food & Drug Administration
Recall

FDA Announces Voluntary Recall of Sandoz Ranitidine Capsules Following Detection of an Impurity

U.S. Food & Drug Administration

PR-M09-19-NI-049Sep 24, 2019
U.S. Food & Drug Administration
Recall

Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab

U.S. Food & Drug Administration

PA2164Sep 05, 2019
Pfizer
Recall

Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® Due to Potential Microbiological Contamination of Non-Sterile Product

Pfizer

PR-M08-19-NI-048Aug 16, 2019
U.S. Food & Drug Administration
Recall

FDA Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from Market

U.S. Food & Drug Administration

PR-M07-19-NI-071Jul 26, 2019
Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States
Recall

Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

Nice Insight

PR-M07-19-NI-062Jul 24, 2019
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products
Recall

Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products

Nice Insight

PR-M07-19-NI-036Jul 15, 2019
Mylan
Recall

Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

Mylan

PR-M03-19-NI-050Mar 19, 2019
U.S. Food & Drug Administration
Drug Recall

FDA Provides Update on its Ongoing Investigation into ARB Drug Products and Losartan Product Recall

U.S. Food & Drug Administration

PR-M03-19-NI-001Mar 01, 2019
Mylan
Recall

Mylan Initiates Voluntary Nationwide Recall Due to the Detection of Trace Amounts of NDEA

Mylan

PR-M11-18-NI-087Nov 26, 2018
Sandoz Issues Voluntary Recall of Losartan
Recall

Sandoz Issues Voluntary Recall of Losartan

Nice Insight

PAO-M11-18-NI-016Nov 20, 2018
Incorrect Dosing Cup Leads to Recall of Children’s Advil Suspension
Pediatric

Incorrect Dosing Cup Leads to Recall of Children’s Advil Suspension

Nice Insight

PAO-M09-18-NI-005Sep 06, 2018
1 / 1